Chronic inflammation and longevity: the slow fire you can actually turn down

Inflamación crónica y longevidad: el fuego lento que sí puedes bajar

Inflammation is your repair crew

Cut your finger and within minutes the area turns red, warm and swollen. That is not the damage. That is the repair arriving.

Your body sends blood, opens the vessels so defense cells can get through, and those cells clear out what is broken and call in the ones that build new tissue. When the job is done, the system sends the other signal: stand down. The swelling settles and new skin is left behind.

That full cycle — switch on, do the work, switch off — is one of the best things you own. You use it to close wounds, to get through the flu, and to build muscle: training breaks fibers, inflammation clears and repairs, and the fiber comes back stronger.

So we are not going to sell you the idea that inflammation is the enemy. It is the opposite. The question in this article is much narrower: what happens when the stand-down signal never arrives.

When the fire does not go out

There are situations where the system stays on at low intensity. Nothing hurts, nothing swells, there is no fever. But there are more inflammatory signals in your blood than there should be, every day, for years.

That is chronic low-grade inflammation. In the paper that organized what we know about aging, the authors listed it as one of the twelve defining hallmarks, alongside things like mitochondrial wear and telomere shortening.

What makes it worth writing about is that, of those twelve, this is one of the few you can see on an ordinary lab panel and move with what you do this week.

What CRP and IL-6 measure (and what they do not)

Two names come up throughout, so they are worth understanding once.

IL-6 (interleukin 6) is a messenger. Cells release it to announce that something needs attention. It is one of the first signals sent.

CRP (C-reactive protein) is what your liver manufactures after receiving that message. That makes CRP a summary: if it is high, messages have been sent. The version that matters here is called high-sensitivity CRP, because it reads accurately in the low range, which is where this whole topic lives.

That same analysis also found higher odds of depression with elevated CRP. And the authors were careful about the rest: for hospitalization and readmission they said outright that the available evidence is still limited.

The caveat that changes how you read everything else

Those 22 studies are observational. They follow large groups for years and compare. That tells you the number travels with the risk. It does not tell you that lowering the number, on its own, changes the ending.

Inflammation may be pushing; it may be the smoke from another fire — visceral fat, broken sleep, an illness that has not declared itself yet; or it may be both at once. In medicine that question gets settled with trials, not cohorts.

We put this up here instead of buried at the bottom because it is the difference between informing you and selling to you. Our job is that you read these numbers with the quotation marks they deserve.

That said, there is something we do know well: what lowers those numbers in people. And the list is surprisingly encouraging.

Strength training: the best-documented lever

If you take one thing from this article, take this one.

An analysis pooled 18 controlled trials in adults aged 60 and over, 539 people in total, and measured what happened to inflammation with resistance training. Not cardio: resistance. Weights, machines, bands, your own body weight.

Now the detail that makes it practical. The authors split the results by age, by training method, by number of exercises, by intensity, by sessions per week and by program length. CRP came down in every subgroup.

Translated: you do not need a perfect program, or an intensity that leaves you wrecked, or five days a week. What shows up again and again is that doing it is what moves the number.

If you are starting out, two days a week built around the big movements — push, pull, squat or stand up from a chair, carry something — is already a program. And if you are on a weight program, strength does a second job you care about: protecting muscle while you eat less.

We go into that in detail in strength training on a GLP-1.

Where a lot of the fire comes from

Here it is worth being precise about something that often gets told wrong.

Fat is not inert padding. It is active tissue that manufactures and releases signals. The fat wrapped around the organs inside your abdomen — visceral fat, the kind you cannot pinch — is the most talkative, and part of what it says are inflammatory messages.

That is why your waist says things the scale does not. Two people at the same weight can carry very different amounts of that fat.

An analysis of 6 trials in 1,246 people with metabolic syndrome measured exactly this. The interventions ran 6 to 12 months, 2 to 5 sessions a week, combining physical activity with changes to food.

Look at adiponectin, which almost nobody mentions. The alarm signals did not just fall: a protective signal went up — one that fat tissue itself produces when it is working well. This is not only switching something bad off. It is getting something good back.

And look at the waist: 3.12 cm on average. That is not a magazine transformation. It is a modest, real, measurable change, with inflammation markers that moved at the same time.

If you want the full mechanism behind why that particular fat causes so much trouble, we cover it in insulin resistance and fatty liver.

Fiber, with one condition

Of everything tested on the food side, fiber comes out best in controlled trials. But the result carries fine print we would rather hand you in full.

An analysis of 14 trials in adults with overweight or obesity found that adding fiber, or fiber-rich foods, lowered CRP by 0.37 mg/L on average.

And here is the condition, which is the useful part: when the studies were split apart, the drop only appeared where the intervention group ended up eating at least 8 grams more fiber a day than the control group. Below that, nothing.

Eight grams is not trivial, but it is not a feat either. A cup of cooked beans gets you most of the way on its own. A pear with the skin, half a cup of lentils, an avocado, a cup of oats: each of those lands somewhere between 4 and 8 grams.

And an honest warning: 0.37 mg/L is a small effect. It will not transform your panel by itself. What makes it worth doing is that it adds in the same direction as everything else, and that fiber brings along things you already want: fullness, calmer digestion and steadier blood sugar.

If you are on a GLP-1 program, we have a guide on raising fiber without making nausea worse: fiber and GLP-1.

Sleep: what the data showed and what it did not

This section contains a finding that is almost always reported backwards, so we will go carefully.

The largest analysis of sleep and inflammation pooled 72 studies and more than 50,000 people. It found three things:

• Disturbed sleep was associated with higher CRP and IL-6. Disturbed means sleeping badly as a pattern: insomnia, waking repeatedly, never feeling rested.
• So was sleeping too much. The extreme of long sleep duration also came with higher CRP and IL-6. Sleeping a lot is not a medal.
• And here is the surprise: deliberately removing sleep in an experiment did not raise these markers. Neither sleep deprivation nor sleep restriction moved CRP, IL-6 or TNF-alpha.

Why does that third point matter? Because it dismantles the easy headline that "one bad night inflames you." That is not what was found. What was found is that sleeping badly over the long run travels with these numbers — a different claim, and a considerably more reassuring one if you have just had a terrible night.

It also means the piece worth protecting is not last night, but the pattern over the next few months. We go further in sleep and weight loss, and into the stress side in stress, cortisol and weight.

What happened when weight actually came down

One obvious question remains: if visceral fat sends inflammatory signals, what happens when that fat goes?

There is a measured answer, and it is one of the most striking figures in this guide. In a trial of 529 people who had obesity and heart failure with preserved ejection fraction, once-weekly semaglutide 2.4 mg was compared against placebo for 52 weeks.

Now the context, which matters as much as the number:

• This was a specific population: people with obesity and one particular type of heart failure. It is not a sample of the general public, and it does not transfer as-is to everyone.
• CRP was a secondary endpoint, not the primary one. The primary endpoints were symptoms and weight.
• The trial does not separate the causes. There is no way to tell from it how much of the drop came from losing fat and how much from a direct effect of the medication.

With those three caveats in place, what remains is still notable: when the fat that manufactures signals is reduced substantially and kept down, the inflammation marker moves a lot, not a little.

And it lines up with the habit-change trials above: less waist, less CRP, less IL-6, more adiponectin. Two different routes, the same direction.

So where do peptides fit?

If you arrived looking for which peptide lowers inflammation, you are owed a direct answer, even if it is not the most marketable one.

They sit alongside everything above, never instead of it. And the quality of the evidence is not the same across the board:

• Some peptides have genuine human trials, and we cover those in their own guides. Thymosin alpha-1 has the longest clinical track record in the catalogue. SS-31 has trials too, though in specific mitochondrial diseases rather than healthy aging.
• Some peptides rest their inflammation claims almost entirely on lab or animal work, not on people. That does not make them false; it makes them not demonstrated in you. Saying which is which is our job.
• And some sit in between — glutathione and MOTS-c, where the mechanism is clear and the human data is still small.

What none of them does is replace strength, sleep, fiber and losing visceral fat. If someone presents one as the shortcut that saves you from the rest, that is not a clinical claim: it is a sale.

The wider frame for where each piece fits is in our anchor article: what longevity really means.

So your expectations match reality

This is a rewarding topic: nearly everything that works is cheap, within reach, and good for other reasons too. So that what you expect matches what can happen:

• A CRP number is not a diagnosis. It rises with a cold, an infected tooth, a hard training session and plenty of other ordinary situations. It is interpreted alongside the rest of your case, and that is your physician's job.
• Lowering CRP is not the goal in itself. What has been shown to travel with better health is the whole package — more strength, less waist, better sleep, better blood sugar — and CRP falls along with them. Chasing the number alone is chasing the smoke instead of the fire.
• The individual effects are modest. 0.37 mg/L from fiber, 3.12 cm of waist from habit change. What is impressive is not any single piece: it is that they all point the same way.
• The timescale is months, not days. The trials we have described ran 6 to 12 months. That is the real scale of this.
• There is no magic anti-inflammatory diet. What does have trials behind it is eating genuinely more fiber, hitting your protein, and not living in sleep debt.
• And the most important one: this is not your fault. A slow fire does not start from a lack of willpower. It starts from mechanisms — visceral fat, broken sleep, years — and mechanisms have levers.

Who is this NOT for?

This section does not change, however much the evidence improves.

• If you have a diagnosed inflammatory disease — rheumatoid arthritis, lupus, inflammatory bowel disease, psoriasis — this article is not about that. Those conditions have their own treatment and decisions that belong to your specialist. Nothing here replaces that treatment.
• If you have just been handed a high CRP and nobody knows why. A high CRP can be an active infection, and that needs an appointment, not a habit plan.
• If you are looking for a supplement that spares you the rest. Nothing with evidence behind it here comes in a capsule.
• If you have kidney disease, liver disease, or a cancer in treatment. These markers are interpreted differently in those situations, and that is not a place to improvise.
• If you are pregnant or breastfeeding. Decisions about medication and supplements belong to your physician, not to an article or a store.
• If you plan to use a peptide instead of lifting or sleeping. You would be trading what has trials for what does not have them yet.

And the rule that applies to everything you read here: do not start, change or stop anything on your own, not even on the strength of a well-cited article. What decides is your case, seen by your physician.

GLP-1 programs with FDA-approved medications (Wegovy®, Foundayo™, Ozempic®) from $149/month, by telemedicine, in Spanish and English

If you read this far, you already know why weight comes up so often in this article: visceral fat is one source of the slow fire, and it is the one that moves most when the work is done properly.

That is exactly why we think a weight program should come with real clinical oversight. Eating much less for months is a medical decision, not only a question of willpower, and there are things worth watching while it happens: muscle, food, sleep and whatever you already take.

That part we can walk with you, in English and Spanish, with continuous follow-up. Cancel whenever you want, in one click.

The path is the same for everything we do: once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary.

Eligibility is determined by medical evaluation. Individual results vary and are not guaranteed.

Frequently asked questions

Is inflammation bad?

No. It is your repair system, and you need it to heal, to clear an infection and to build muscle. The problem is not that it switches on: it is that it does not switch off for months or years.

How do I know if I have chronic inflammation?

You cannot tell from symptoms: it does not hurt or swell. It shows up on ordinary blood work, mainly high-sensitivity CRP and IL-6. Who orders those and how they are read is your physician's call, because a number on its own does not mean the same thing in every situation.

What lowers inflammation most, according to the studies?

Among things tested in people, resistance training is the best documented: across 18 trials in adults aged 60 and over it lowered CRP consistently. And changing habits for 6 to 12 months lowered CRP, IL-6 and waist circumference together in people with metabolic syndrome.

How much fiber does it take?

In the analysis of 14 trials, the effect on CRP only appeared where people ate at least 8 grams more fiber a day than the control group. A cup of cooked beans gets you most of the way on its own.

If I sleep badly one night, am I inflamed?

That is not what was found. In the analysis of 72 studies, deliberately removing sleep in an experiment did not raise CRP, IL-6 or TNF-alpha. What did travel with those markers was sleeping badly as a sustained pattern.

Will lowering my CRP make me live longer?

That has not been shown, and we are not going to tell you otherwise. The studies linking high CRP to higher mortality are observational: they show the number travels with the risk, not that lowering it on its own changes the outcome.

Which peptide is the best anti-inflammatory?

There is no honest answer to that question yet. Some peptides in the catalogue have human trials and others support their inflammation claims almost entirely with lab or animal studies. In each individual guide we say which is which.

Is there an anti-inflammatory diet?

Not under that name and not with that strength of evidence. What does have controlled trials behind it is genuinely raising fiber and changing food and activity habits over months. Lists of "anti-inflammatory foods" usually promise more than has been measured.

How long before anything changes?

Months. The trials we cite ran 6 to 12 months. That is the real scale here, and it is worth knowing before you start so you do not quit in week three.

Do I need labs before starting anything?

Once you start your program, a licensed physician reviews your case — habits, stress, sleep and medical history — and orders labs only if they consider it necessary. It is not automatic and not required for everyone.

Sources

• Chen D, Tam WWS, Zhang J, Lu J, Wu VX. Association between the inflammageing biomarkers and clinical outcomes amongst the community-dwelling middle-aged and older adults: a systematic review and meta-analysis. Ageing Res Rev. 2025;110:102811. — DOI · via PubMed
• Kim SD, Yeun YR. Effects of resistance training on C-reactive protein and inflammatory cytokines in elderly adults: a systematic review and meta-analysis of randomized controlled trials. Int J Environ Res Public Health. 2022;19(6):3434. — DOI · via PubMed
• Rahimi GRM, Yousefabadi HA, Niyazi A, Rahimi NM, Alikhajeh Y. Effects of lifestyle intervention on inflammatory markers and waist circumference in overweight/obese adults with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Biol Res Nurs. 2022;24(1):94-105. — DOI · via PubMed
• Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40-52. — DOI · via PubMed
• Jiao J, Xu JY, Zhang W, Han S, Qin LQ. Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: a meta-analysis of randomized controlled trials. Int J Food Sci Nutr. 2015;66(1):114-119. — DOI · via PubMed
• Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069-1084. — DOI · via PubMed
• López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243-278. — DOI · via PubMed

Per-food fiber figures come from FoodData Central, the food composition database of the United States Department of Agriculture.

Your trust is worth more than a sale.

More information →

This article is informational and is not medical advice. SCTS1 does not prescribe medication. All medical care, prescriptions and treatment plans are provided by licensed physicians through our partner platform, and preparations are dispensed by licensed pharmacies. Eligibility is determined by a licensed provider through medical evaluation. The studies cited on inflammation and mortality are observational and do not demonstrate cause and effect. The semaglutide data come from a trial in people with obesity and heart failure with preserved ejection fraction and do not transfer automatically to other situations; C-reactive protein was a secondary endpoint in that trial. Chronic low-grade inflammation is not a diagnosable disease on its own, and nothing described here replaces treatment for an inflammatory disease. Do not start, change or stop any medication or supplement on your own. Individual results vary and are not guaranteed.